Genomic Classification of Cutaneous Melanoma
- PMID: 26091043
- PMCID: PMC4580370
- DOI: 10.1016/j.cell.2015.05.044
Genomic Classification of Cutaneous Melanoma
Abstract
We describe the landscape of genomic alterations in cutaneous melanomas through DNA, RNA, and protein-based analysis of 333 primary and/or metastatic melanomas from 331 patients. We establish a framework for genomic classification into one of four subtypes based on the pattern of the most prevalent significantly mutated genes: mutant BRAF, mutant RAS, mutant NF1, and Triple-WT (wild-type). Integrative analysis reveals enrichment of KIT mutations and focal amplifications and complex structural rearrangements as a feature of the Triple-WT subtype. We found no significant outcome correlation with genomic classification, but samples assigned a transcriptomic subclass enriched for immune gene expression associated with lymphocyte infiltrate on pathology review and high LCK protein expression, a T cell marker, were associated with improved patient survival. This clinicopathological and multi-dimensional analysis suggests that the prognosis of melanoma patients with regional metastases is influenced by tumor stroma immunobiology, offering insights to further personalize therapeutic decision-making.
Copyright © 2015 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Targeted Genomic Profiling of Acral Melanoma.J Natl Cancer Inst. 2019 Oct 1;111(10):1068-1077. doi: 10.1093/jnci/djz005. J Natl Cancer Inst. 2019. PMID: 30657954 Free PMC article.
-
GAB2 amplifications refine molecular classification of melanoma.Clin Cancer Res. 2009 Jul 1;15(13):4288-91. doi: 10.1158/1078-0432.CCR-09-0280. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509136 Free PMC article.
-
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations.Mod Pathol. 2020 Dec;33(12):2397-2406. doi: 10.1038/s41379-020-0581-5. Epub 2020 Jun 1. Mod Pathol. 2020. PMID: 32483240 Free PMC article.
-
The NF1 gene in tumor syndromes and melanoma.Lab Invest. 2017 Feb;97(2):146-157. doi: 10.1038/labinvest.2016.142. Epub 2017 Jan 9. Lab Invest. 2017. PMID: 28067895 Free PMC article. Review.
-
Toward a molecular classification of melanoma.J Clin Oncol. 2007 Apr 20;25(12):1606-20. doi: 10.1200/JCO.2006.06.0442. J Clin Oncol. 2007. PMID: 17443002 Review.
Cited by
-
Melanoma genomics - will we go beyond BRAF in clinics?J Cancer Res Clin Oncol. 2024 Sep 28;150(9):433. doi: 10.1007/s00432-024-05957-2. J Cancer Res Clin Oncol. 2024. PMID: 39340537 Free PMC article. Review.
-
Strongly ROS-Correlated, Time-Dependent, and Selective Antiproliferative Effects of Synthesized Nano Vesicles on BRAF Mutant Melanoma Cells and Their Hyaluronic Acid-Based Hydrogel Formulation.Int J Mol Sci. 2024 Sep 19;25(18):10071. doi: 10.3390/ijms251810071. Int J Mol Sci. 2024. PMID: 39337557 Free PMC article.
-
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects.Biomedicines. 2024 Sep 2;12(9):1979. doi: 10.3390/biomedicines12091979. Biomedicines. 2024. PMID: 39335494 Free PMC article. Review.
-
Oxidative State in Cutaneous Melanoma Progression: A Question of Balance.Antioxidants (Basel). 2024 Aug 30;13(9):1058. doi: 10.3390/antiox13091058. Antioxidants (Basel). 2024. PMID: 39334716 Free PMC article. Review.
-
Application of Single Cell Type-Derived Spheroids Generated by Using a Hanging Drop Culture Technique in Various In Vitro Disease Models: A Narrow Review.Cells. 2024 Sep 14;13(18):1549. doi: 10.3390/cells13181549. Cells. 2024. PMID: 39329734 Free PMC article. Review.
References
-
- Andersen LB, Fountain JW, Gutmann DH, Tarlé SA, Glover TW, Dracopoli NC, Housman DE, Collins FS. Mutations in the neuro-fibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet. 1993;3:118–121. - PubMed
-
- Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30:2678–2683. - PubMed
-
- Baade P, Meng X, Youlden D, Aitken J, Youl P. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006. Int J Cancer. 2012;130:170–178. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 CA143882/CA/NCI NIH HHS/United States
- U24 CA143866/CA/NCI NIH HHS/United States
- U24 CA143843/CA/NCI NIH HHS/United States
- U24 CA143858/CA/NCI NIH HHS/United States
- U24 CA143848/CA/NCI NIH HHS/United States
- U24 CA143883/CA/NCI NIH HHS/United States
- 21141/CRUK_/Cancer Research UK/United Kingdom
- U24 CA143867/CA/NCI NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- P30 CA016672/CA/NCI NIH HHS/United States
- U54 HG003067/HG/NHGRI NIH HHS/United States
- U24 CA143835/CA/NCI NIH HHS/United States
- U24 CA143845/CA/NCI NIH HHS/United States
- U24 CA143799/CA/NCI NIH HHS/United States
- T32 GM007753/GM/NIGMS NIH HHS/United States
- U54 HG003273/HG/NHGRI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- U24 CA144025/CA/NCI NIH HHS/United States
- R01 CA163896/CA/NCI NIH HHS/United States
- U24 CA180951/CA/NCI NIH HHS/United States
- U24 CA143840/CA/NCI NIH HHS/United States
- P50 CA121974/CA/NCI NIH HHS/United States
- U54 HG003079/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous